Major new ‘will not work in emergency' recall as defibrillator model urgently pulled from shelves amid ‘remove' alert
A MAJOR warning has been issued to people using an essential health device as the product has been issued a recall.
A certain amount of the Zoll Powerheart G5 AED defibrillators have a flaw which means the device may not
A defibrillator is a
Homeowners,
However, as they provide essential resuscitation, it is absolutely necessary that they work properly.
As such, the potentially faulty device has been
READ MORE IRISH NEWS
The Health Products Regulatory Authority issued the recall yesterday.
The affected item is the Zoll Powerheart G5 AED with the error code EC 501.
It is important to note that not all products of this kind are affected, it is only the ones with the error code.
The error code should show up on its own after undergoing self-tests.
MOST READ ON THE IRISH SUN
Bosses said that if the code shows up, the device will not able to deliver lifesaving therapy.
What is myeloma?
They advised that if the error code shows up, you should stop using the device.
They added that the device should then be replaced and kept at its recommended humidity level.
The HPRA said: "The HPRA is issuing this Safety Notice to raise awareness of an issue affecting the Powerheart G5 AED, whereby the device may not deliver therapy when needed.
"After performing normally scheduled self-tests, Powerheart G5 AEDs may display Error Code (EC) 501 and be unable to deliver lifesaving therapy while in this state.
"The issue can be detected during routine inspection."
But health bosses said that the rate of acknowledgement from users in Ireland was very low, meaning not everyone is aware of the issue.
They said they have issued the safety notice to make people aware of the issue and ensure they take the correct steps to fix it.
The HPRA took to
Posting on
"If your AED shows Error Code EC 501 during a self-test, this means it will not work in an emergency.
"Check your device regularly. If you see this error during a self-test, follow the recommended actions."
1
The product has been recalled due to a risk
Credit: HealthProductsRegulatoryAuthority
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Daily Mirror
a day ago
- Irish Daily Mirror
Revenue seize hundreds of parcels of illegal weight loss medication
Revenue have seized hundreds of parcels of illegal weight loss and other medical products, including items packaged as Ozempic, in operations over recent weeks. Revenue's Customs Service conducted a number of operations throughout the last few weeks targeting the illicit importation of weight loss and other medical products. These operations were conducted as a result of enhanced risk profiling techniques used by Revenue. In one such operation, assisted by the Health Products Regulatory Authority (HPRA), a total of 85 shipments of illicit medical products were identified. This included items packaged as Ozempic, Wegovy, and Mounjaro. Further detections over the course of the operation resulted in the interception of additional products packaged as Tirzepatide. In a separate operation, conducted over the course of a two-week period, 635 detections were made whilst Revenue officers were examining parcels at premises in Dublin and the Midlands. These parcels contained a range of illicit medical products packaged as Semaglutide, together with substantial volumes of previously unknown Botox-type and tanning products believed to have been sourced via social media. These seizures reflect an emerging trend noted by Revenue officers, particularly those based at the national mail centres and courier hubs, who have seen a significant increase in packages containing mail order prescription-only medical products. The vast majority of packages intercepted contain weight-loss products addressed to private individuals who have purchased these products online. Larger consignments are occasionally detected at ports and airports. As at 31 May 2025, Revenue enforcement teams have seized almost 11,000 individual weight loss products during the course of various ongoing operations. This is a significant increase on the 2,300 individual products seized over the course of 2024. Our work in this space is supported by advanced risk analysis, profiling and the range of assets available to us. Our strategy also involves developing and sharing intelligence on a national, EU and international basis, and we continue to adopt an agile response to ensure that we deploy our resources optimally to counteract new risk areas as they develop. Consumers are reminded that it is important to take care when purchasing medical products online, as they may not be safe or effective. Consumers should also be cautious as they may suffer a financial loss if goods they purchase are subsequently seized because they are subject to restrictions. A spokesperson for Revenue said investigations in respect of all operations are ongoing.
Irish Independent
2 days ago
- Irish Independent
‘Significant increase' in weight loss drugs like Ozempic being seized in Revenue operations
A number of operations have been carried out by Revenue customs service targeting weight-loss and other medical products. In one operation assisted by the Health Products Regulatory Authority (HPRA), 85 shipments of illicit weight-loss products were identified packaged as Ozempic and other brands including Wegovy and Mounjaro. During this operation, additional products packaged as the anti-diabetic and weight-loss medication Tirzepatide were intercepted. Another operation carried out over two weeks saw Revenue officers examine parcels at premises in Dublin and the midlands, where they made 635 detections of products. The parcels were found to contain products including illicit medical products packaged as semaglutide, the active ingredient in Ozempic and Wegovy, and 'substantial volumes of unknown Botox-type and tanning products believed to have been sourced via social media'. A spokesperson said these seizures 'reflect an emerging trend noted by Revenue officers', particularly those based at national mail centres and courier hubs, of a 'significant increase' in the number of packages containing prescription only medical products ordered by mail. They said the 'vast majority' of these intercepted packaged contained weight-loss products addressed to private individuals who bought them online. Larger consignments of the goods are also occasionally detected at ports and airports. Revenue enforcement teams have almost 11,000 individual weight-loss products over the course of all operations, as of May 31. This marks a 'significant increase' on the 2,300 individual products seized all of last year. Consumers have been issued a reminder of the importance of taking care when buying medical products online, 'as they may not be safe or effective'. They have also been advised to be cautious as they could suffer a financial loss if the goods they buy are seized. Investigations in respect of all operation carried out by Revenue are ongoing. In April, the HPRA announced more than one million units of illegal medicines had been seized last year, up 14pc on 2023. This included 203,088 units of anabolic steroids, 146,866 units of sedative drugs, 119,289 units of erectile dysfunction medicines and 113,555 analgesic drugs used for the treatment of pain. The HPRA noted an upward trend in the use of medical weight-loss products like Ozempic. 'While purchasing online is second nature for many of us, when it comes to prescription medicines, people need to ensure that the product is prescribed by a healthcare professional and sourced from a local pharmacy,' HPRA director of compliance Grainne Power said. 'Your pharmacy has sourced medicines from authorised sources for your protection and is an expert in their use. Using these prescription medicines without medical supervision or from an unregulated source leaves people unprotected. 'The seizure of over one million dosage units of illegal medicines last year highlights the persistent extent of the threats posed by falsified and unauthorised prescription medicines.'
The Irish Sun
4 days ago
- The Irish Sun
Major new ‘will not work in emergency' recall as defibrillator model urgently pulled from shelves amid ‘remove' alert
A MAJOR warning has been issued to people using an essential health device as the product has been issued a recall. A certain amount of the Zoll Powerheart G5 AED defibrillators have a flaw which means the device may not A defibrillator is a Homeowners, However, as they provide essential resuscitation, it is absolutely necessary that they work properly. As such, the potentially faulty device has been READ MORE IRISH NEWS The Health Products Regulatory Authority issued the recall yesterday. The affected item is the Zoll Powerheart G5 AED with the error code EC 501. It is important to note that not all products of this kind are affected, it is only the ones with the error code. The error code should show up on its own after undergoing self-tests. MOST READ ON THE IRISH SUN Bosses said that if the code shows up, the device will not able to deliver lifesaving therapy. What is myeloma? They advised that if the error code shows up, you should stop using the device. They added that the device should then be replaced and kept at its recommended humidity level. The HPRA said: "The HPRA is issuing this Safety Notice to raise awareness of an issue affecting the Powerheart G5 AED, whereby the device may not deliver therapy when needed. "After performing normally scheduled self-tests, Powerheart G5 AEDs may display Error Code (EC) 501 and be unable to deliver lifesaving therapy while in this state. "The issue can be detected during routine inspection." But health bosses said that the rate of acknowledgement from users in Ireland was very low, meaning not everyone is aware of the issue. They said they have issued the safety notice to make people aware of the issue and ensure they take the correct steps to fix it. The HPRA took to Posting on "If your AED shows Error Code EC 501 during a self-test, this means it will not work in an emergency. "Check your device regularly. If you see this error during a self-test, follow the recommended actions." 1 The product has been recalled due to a risk Credit: HealthProductsRegulatoryAuthority
